MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Solution

国药准字H20223974

December 30, 2022

Drug Information

盐酸左西替利嗪口服溶液

口服溶液剂

0.05%(150ml:75mg)

化学药品

December 30, 2022

Company Information

Applicant Company

浙江省湖州市三天门路2号

Manufacturing Company

浙江省兰溪市康恩贝大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服溶液 - NMPA 批准文号 | MedPath